Relouw F, Kox M, Taal H, Koch B, Prins M, Van Riel N
NPJ Syst Biol Appl. 2024; 10(1):146.
PMID: 39638779
PMC: 11621538.
DOI: 10.1038/s41540-024-00473-y.
Zhang H, Liang R, Zhu Y, Hu L, Xia H, Li J
BMC Infect Dis. 2024; 24(1):187.
PMID: 38347444
PMC: 10863141.
DOI: 10.1186/s12879-024-09043-3.
Liu Q, Fan X, Cui W, Wang X, Zhang Z, Wang N
Turk J Anaesthesiol Reanim. 2023; 51(5):408-413.
PMID: 37876167
PMC: 10606736.
DOI: 10.4274/TJAR.2023.231349.
Wang W, Gu X, Cao Z, Wang X, Lei Y, Xu X
Lipids Health Dis. 2023; 22(1):111.
PMID: 37525169
PMC: 10388529.
DOI: 10.1186/s12944-023-01879-z.
Schupp T, Weidner K, Rusnak J, Jawhar S, Forner J, Dulatahu F
Ir J Med Sci. 2023; 193(1):457-468.
PMID: 37204560
PMC: 10196281.
DOI: 10.1007/s11845-023-03385-8.
C9 immunostaining as a tissue biomarker for periprosthetic joint infection diagnosis.
Meinshausen A, Farber J, Illiger S, Macor P, Lohmann C, Bertrand J
Front Immunol. 2023; 14:1112188.
PMID: 36895567
PMC: 9989178.
DOI: 10.3389/fimmu.2023.1112188.
Current Status of Antibiotic Stewardship and the Role of Biomarkers in Antibiotic Stewardship Programs.
Kim C
Infect Chemother. 2023; 54(4):674-698.
PMID: 36596680
PMC: 9840952.
DOI: 10.3947/ic.2022.0172.
screening for oligopeptides useful as capture and reporting probes for interleukin-6 biosensing.
Mastouri M, Baachaoui S, Mosbah A, Raouafi N
RSC Adv. 2022; 12(21):13003-13013.
PMID: 35497015
PMC: 9049833.
DOI: 10.1039/d2ra01496c.
Clinical Characteristics of Bloodstream Infection in Immunosuppressed Patients: A 5-Year Retrospective Cohort Study.
Lin H, Yang L, Fang J, Gao Y, Zhu H, Zhang S
Front Cell Infect Microbiol. 2022; 12:796656.
PMID: 35444962
PMC: 9014008.
DOI: 10.3389/fcimb.2022.796656.
Stellate ganglion block reduces inflammation and improves neurological function in diabetic rats during ischemic stroke.
Li T, Wan Q, Zhang X, Xiao Y, Sun L, Zhang Y
Neural Regen Res. 2022; 17(9):1991-1997.
PMID: 35142688
PMC: 8848600.
DOI: 10.4103/1673-5374.335162.
Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients.
Ishikawa S, Teshima Y, Otsubo H, Shimazui T, Nakada T, Takasu O
BMC Emerg Med. 2021; 21(1):132.
PMID: 34749673
PMC: 8573766.
DOI: 10.1186/s12873-021-00534-z.
Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection.
Chaftari P, Qdaisat A, Chaftari A, Maamari J, Li Z, Lupu F
Cancers (Basel). 2021; 13(16).
PMID: 34439240
PMC: 8393196.
DOI: 10.3390/cancers13164087.
Endothelial Dysfunction and Neutrophil Degranulation as Central Events in Sepsis Physiopathology.
Martin-Fernandez M, Tamayo-Velasco A, Aller R, Gonzalo-Benito H, Martinez-Paz P, Tamayo E
Int J Mol Sci. 2021; 22(12).
PMID: 34200950
PMC: 8230689.
DOI: 10.3390/ijms22126272.
Prognostic predictors in patients with sepsis after gastrointestinal tumor surgery: A retrospective study.
Chen R, Wu Z, Li Z, Wang H, Ji J
World J Gastrointest Surg. 2021; 13(3):256-266.
PMID: 33796214
PMC: 7992996.
DOI: 10.4240/wjgs.v13.i3.256.
Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection.
Hariyanto T, Kurniawan A
J Med Virol. 2020; 93(3):1832-1836.
PMID: 33241872
PMC: 7753293.
DOI: 10.1002/jmv.26698.
Association of elevated inflammatory markers and severe COVID-19: A meta-analysis.
Ji P, Zhu J, Zhong Z, Li H, Pang J, Li B
Medicine (Baltimore). 2020; 99(47):e23315.
PMID: 33217868
PMC: 7676531.
DOI: 10.1097/MD.0000000000023315.
Interleukin-6 as inflammatory marker of surgical site infection following spinal surgery.
Lenski M, Tonn J, Siller S
Acta Neurochir (Wien). 2020; 163(6):1583-1592.
PMID: 33118112
DOI: 10.1007/s00701-020-04628-8.
Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis.
Ding J, Su S, You T, Xia T, Lin X, Chen Z
Clinics (Sao Paulo). 2020; 75:e1801.
PMID: 33084768
PMC: 7536892.
DOI: 10.6061/clinics/2020/e1801.
Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
Paniri A, Akhavan-Niaki H
Life Sci. 2020; 257:118114.
PMID: 32693241
PMC: 7368418.
DOI: 10.1016/j.lfs.2020.118114.
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.
Zhang C, Wu Z, Li J, Zhao H, Wang G
Int J Antimicrob Agents. 2020; 55(5):105954.
PMID: 32234467
PMC: 7118634.
DOI: 10.1016/j.ijantimicag.2020.105954.